184 related articles for article (PubMed ID: 20501425)
1. [Role of matrix metalloproteinase in transformation of subdural effusion into chronic subdural hematoma].
Wang ZF; Liao DG
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1188-9. PubMed ID: 20501425
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinase-9 and -2 in pediatric chronic otitis media with effusion.
Jang CH; Shin SH; Cho HH; Moon SJ; Cho YB
Int J Pediatr Otorhinolaryngol; 2006 Jul; 70(7):1155-8. PubMed ID: 16413616
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics of chronic subdural hematoma evolving from traumatic subdural effusion].
Liu Y; Zhu S; Jiang Y; Li G; Li X; Su W; Wu C
Zhonghua Wai Ke Za Zhi; 2002 May; 40(5):360-2. PubMed ID: 12133342
[TBL] [Abstract][Full Text] [Related]
4. Role of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, and Vascular Endothelial Growth Factor in the Development of Chronic Subdural Hematoma.
Hua C; Zhao G; Feng Y; Yuan H; Song H; Bie L
J Neurotrauma; 2016 Jan; 33(1):65-70. PubMed ID: 25646653
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological classification of chronic subdural hematoma.
Yamashima T; Yamamoto S
Zentralbl Neurochir; 1985; 46(4):304-14. PubMed ID: 3832696
[TBL] [Abstract][Full Text] [Related]
6. [Study on expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in brain tissue adjacent to hemorrhage after brain hemorrhage in human].
Ke SF; Jin XP; Zhang KH; Wang JX; Hu XM; Zhang DH; Chen QY; Zhou YL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jun; 19(6):336-9. PubMed ID: 17577437
[TBL] [Abstract][Full Text] [Related]
7. Traumatic subdural hydroma developing into chronic subdural hematoma.
Liu YG; Xu CJ; Zhu SG; Jiang YQ; Li G; Li XG; Su WD; Wu CY
Chin J Traumatol; 2004 Jun; 7(3):188-90. PubMed ID: 15294120
[TBL] [Abstract][Full Text] [Related]
8. Gelatinolytic activities (matrix metalloproteinase-2 and -9) and soluble extracellular domain of Her-2/neu in pleural effusions.
Di Carlo A; Mariano A; Terracciano D; Mazzarella C; Galzerano S; Cicalese M; Cecere C; Macchia V
Oncol Rep; 2007 Aug; 18(2):425-31. PubMed ID: 17611666
[TBL] [Abstract][Full Text] [Related]
9. [Significance of the factors in wound healing for the origin of chronic subdural hematoma--fibronectin and its related substances].
Nishida S
No To Shinkei; 1992 Jun; 44(6):565-70. PubMed ID: 1389564
[TBL] [Abstract][Full Text] [Related]
10. Correlation of metalloproteinase-2 and -9 with proinflammatory cytokines interleukin-1b, interleukin-12 and the interleukin-1 receptor antagonist in patients with chronic uveitis.
El-Shabrawi YG; Christen WG; Foster SC
Curr Eye Res; 2000 Mar; 20(3):211-4. PubMed ID: 10694897
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-2 and -9 exacerbate arterial stiffening and angiogenesis in diabetes and chronic kidney disease.
Chung AW; Yang HH; Sigrist MK; Brin G; Chum E; Gourlay WA; Levin A
Cardiovasc Res; 2009 Dec; 84(3):494-504. PubMed ID: 19617223
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between expressions of matrix metalloproteinase-2 & 9 and vasculogenic mimicry in gastrointestinal stromal tumors].
Qie S; Sun BC; Zhao XL; Zhang SW; Sun T; Gao SY; Wang XH
Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(16):1106-9. PubMed ID: 19595140
[TBL] [Abstract][Full Text] [Related]
13. The expression of MMP-2, MMP-7, MMP-9, and TIMP-1 in chronic rhinosinusitis and nasal polyposis.
Can IH; Ceylan K; Caydere M; Samim EE; Ustun H; Karasoy DS
Otolaryngol Head Neck Surg; 2008 Aug; 139(2):211-5. PubMed ID: 18656717
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinases in the chronic subdural haematoma membrane.
Nakagawa T; Kodera T; Kubota T
Acta Neurochir (Wien); 2000; 142(1):61-6. PubMed ID: 10664377
[TBL] [Abstract][Full Text] [Related]
15. Rhinovirus upregulates matrix metalloproteinase-2, matrix metalloproteinase-9, and vascular endothelial growth factor expression in nasal polyp fibroblasts.
Wang JH; Kwon HJ; Jang YJ
Laryngoscope; 2009 Sep; 119(9):1834-8. PubMed ID: 19572270
[TBL] [Abstract][Full Text] [Related]
16. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V
J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906
[TBL] [Abstract][Full Text] [Related]
17. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma.
Patel BP; Shah PM; Rawal UM; Desai AA; Shah SV; Rawal RM; Patel PS
J Surg Oncol; 2005 May; 90(2):81-8. PubMed ID: 15844188
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms.
Furuya M; Ishikura H; Kawarada Y; Ogawa Y; Sakuragi N; Fujimoto S; Yoshiki T
Gynecol Oncol; 2000 Aug; 78(2):106-12. PubMed ID: 10926788
[TBL] [Abstract][Full Text] [Related]
19. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer.
Shah FD; Shukla SN; Shah PM; Shukla HK; Patel PS
Indian J Cancer; 2009; 46(3):194-202. PubMed ID: 19574670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
